AllianceRx Walgreens Prime expands offerings
AllianceRx Walgreens Prime announced additional medicines available to patients with certain rare, chronic and complex conditions.
Pharmacy
Delivering improved outcomes with central fill technology
An aging population, rising drug costs, DIR fees, value-based insurance plans, disruptive new market players and new specialty drugs are just a few of the rapidly evolving trends that continue to put pressure on the industry and pull pharmacy staff in directions that take time away from consultative
Technology: Advancing the practice of pharmacy
It’s no secret that community pharmacy is facing a period of tremendous challenge.
Giant Eagle partners with higi
CHICAGO – higi, a consumer health engagement company who partners with leading retailers and health care companies to provide access points to care via a connected network of smart health stations, announced on Monday a new partnership with Giant Eagle Supermarkets.
Sandoz will appeal District Court of New Jersey ruling in biosimilar Erelzi U.S. patent case
HOLZKIRCHEN, Germany – Sandoz, a Novartis division and a global leader in biosimilars, today announced that the United States District Court of New Jersey ruled against Sandoz in patent litigation concerning the Sandoz biosimilar, Erelzi (etanercept-szzs) for reference medicine Enbrel (etanercept).
Diplomat signs exclusive practice-based infusion agreement with Allergy Partners
Diplomat Pharmacy announced an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office and in-home delivery and administration of infusion drugs and biologics.
Diplomat announces second quarter results, to review strategic alternatives
Diplomat Pharmacy announced financial results for the quarter ended June 30, 2019. Revenue decreased 9% from $1.4 billion to $1.2 billion and gross profit decreased from $98.4 million to $72.7 million from the prior-year quarter. Adjusted EBITDA was $19.3 million compared to $42.
Study: Certified pharmacy technicians more committed to a career
New research shows nationally certified pharmacy technicians are more committed to a pharmacy career and have a greater desire to take on new and expanded responsibilities than noncertified.
Walmart, Petco and Chewy invest in $9 billion pet medication market
By mid-year, 2019 had already been quite a year in the pet medications market, with Chewy.
Hanna named Neighbourhood Pharmacy Association of Canada’s interim CEO
The Neighbourhood Pharmacy Association of Canada (Neighbourhood Pharmacies) announced Thursday that Sandra Hanna will take on the role of interim chief executive officer effective September 3, 2019.
The American Cancer Society and CVS Health team up on fundraiser
ATLANTA – The American Cancer Society, the nation’s largest voluntary health organization dedicated to eliminating cancer, announced this week the launch of an in-store fundraising campaign at CVS Pharmacy locations across the country, as part of its national collaboration with CVS Health.
Scarborough and Weiland to join Cardinal Health’s board
Cardinal Health announced that Dean Scarborough, former chairman and chief executive officer of Avery Dennison Corp., and John Weiland, former vice chairman, president and chief operating officer of C.R. Bard, Inc., will join its board of directors effective September 1.
NASP releases agenda for 4th Annual Specialty Pharmacy Law Conference
The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing all specialty pharmacy industry stakeholders, is pleased to announce the full agenda for the 4th Annual Specialty Pharmacy Law Conference. The conference will take place Thursday, Sept.
Upper East Chemists opens in NYC
Upper East Chemists, a family-owned luxury drug store and neighborhood purveyor of natural health products, is now open at 1401 3rd Avenue at 80th Street.
CVS expands CarePass program nationwide
CVS Pharmacy announced Monday that customers will be able to enroll in CarePass at participating CVS Pharmacy locations nationwide, or online at CVS.com/carepass.
Aurobindo gets FDA approval for fenofibric acid delayed-release capsules
EAST WINDSOR, N.J. – Aurobindo has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for fenofibric acid delayed-release capsules, 45 mg and 135 mg.